A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices

medicalxpress - A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Re…

AI Summary: Researchers have identified HORMAD1, a normally reproductive‑cell gene, as a vulnerability in some triple‑negative breast cancers. Preclinical work suggests exploiting this target could guide patient selection and novel therapies, opening a promising — if early‑stage — route for a tumor type that desperately needs smarter options.

• HORMAD1: reproductive gene reveals vulnerability in triple‑negative breast cancer (3)
• New insights into why aggressive breast cancers grow and spread (3)
• OTHER: related cancer research and approvals outside this TNBC angle (5)
• All Other Stories

HORMAD1: reproductive gene reveals vulnerability in triple‑negative breast cancer

New insights into why aggressive breast cancers grow and spread

OTHER: related cancer research and approvals outside this TNBC angle

All Other Stories